{
  "id": 2382030,
  "title": "Boosting cell cleanup process may protect against glaucoma",
  "url": "https://urgent.news/2026/08/21/boosting-cell-cleanup-process-may-protect-against-glaucoma",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-21T13:40:01.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-boosting-cell-cleanup-glaucoma.html"
  },
  "original_language": "en",
  "account": "Glaucoma, a neurodegenerative eye disorder, results from the progressive loss of retinal ganglion cells (RGCs) and damage to the optic nerve. This condition often progresses silently, leading to irreversible vision loss before patients even notice any issues. Researchers at the University of Missouri School of Medicine are investigating methods to delay or halt this degeneration. Their recent study reveals that a drug called Torin 2, which enhances the cell's cleanup mechanism known as autophagy, can help preserve RGCs and alleviate glaucoma-related neurodegeneration. Autophagy acts like the cell's natural recycling system, removing and recycling damaged cellular components, such as mitochondria. In glaucoma, impaired autophagy leads to the accumulation of damaged mitochondria, which contribute to RGC degeneration. The mitochondria, responsible for energy production within cells, work harder and degrade more rapidly in these conditions, necessitating constant repair. When damaged mitochondria are not adequately eliminated, they can accumulate, causing cellular stress and further degeneration. The study utilized two glaucoma models and applied Torin 2, a drug that boosts autophagy, which successfully maintained a greater number of RGCs and improved their functionality. Although Torin 2 is not yet approved for human use, these findings indicate that targeting and enhancing autophagy could offer a protective effect against cell loss in glaucoma. The researchers emphasize the importance of restoring the cell's ability to clear damaged mitochondria to safeguard RGCs. Moving forward, they aim to discover more targeted and clinically applicable approaches to support the body's autophagy and mitochondrial quality control. This strategy could potentially complement existing treatments that reduce eye pressure and preserve vision. Prabhavathi Maddineni, the lead author and assistant professor of ophthalmology at the University of Missouri School of Medicine, is dedicated to understanding glaucoma-related degeneration and neuroinflammation.",
  "summary": "Glaucoma is a neurodegenerative eye disease defined by the progressive death of nerve cells in the retina called retinal ganglion cells (RGCs) and damage to the optic nerve. It doesn't have many warning signs, so significant and irreversible vision loss can occur before patients even realize what's happening.",
  "key_points": [
    "Torin 2 drug enhances cell cleanup mechanism autophagy",
    "Improves retinal ganglion cell preservation, reduces glaucoma neurodegeneration",
    "Study on glaucoma models shows Torin 2 maintains RGCs and functionality"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}